Daniel H Kett
Overview
Explore the profile of Daniel H Kett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1487
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rosa R, dePascale D, Cleary T, Fajardo-Aquino Y, Kett D, Munoz-Price L
Am J Infect Control
. 2014 May;
42(7):755-7.
PMID: 24792716
Background: Acinetobacter baumannii is a pathogen of importance worldwide. Methods: From January 2011 until January 2012, environmental and surveillance cultures were collected from patients admitted to our intensive care units...
12.
Munoz-Price L, Carling P, Cleary T, Fajardo-Aquino Y, dePascale D, Jimenez A, et al.
Am J Infect Control
. 2014 Apr;
42(5):466-71.
PMID: 24773784
Background: Our institution continued to experience a hyperendemic situation with carbapenem-resistant Acinetobacter baumannii despite a bundle of interventions. We aim to describe the effect of the subsequent implementation of electronic...
13.
Rosa R, Arheart K, dePascale D, Cleary T, Kett D, Namias N, et al.
Infect Control Hosp Epidemiol
. 2014 Mar;
35(4):430-3.
PMID: 24602951
We aimed to determine the association between environmental exposure to carbapenem-resistant Acinetobacter baumannii and the subsequent risk of acquiring this organism. Patients exposed to a contaminated hospital environment had 2.77...
14.
Vazquez J, Reboli A, Pappas P, Patterson T, Reinhardt J, Chin-Hong P, et al.
BMC Infect Dis
. 2014 Feb;
14:97.
PMID: 24559321
Background: Hospitalized patients are at increased risk for candidemia and invasive candidiasis (C/IC). Improved therapeutic regimens with enhanced clinical and pharmacoeconomic outcomes utilizing existing antifungal agents are still needed. Methods:...
15.
Quartin A, Scerpella E, Puttagunta S, Kett D
BMC Infect Dis
. 2013 Nov;
13:561.
PMID: 24279701
Background: Acceptance of healthcare-associated pneumonia (HCAP) as an entity and the associated risk of infection by potentially multidrug-resistant (MDR) organisms such as methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas and Acinetobacter have...
16.
Ferrada M, Quartin A, Kett D, Morris M
BMC Anesthesiol
. 2013 Nov;
13(1):37.
PMID: 24172136
Background: Mortality among critically ill patients with candidemia is very high. We sought to determine whether the choice of initial antifungal therapy is associated with survival among these patients, using...
17.
Caceres F, Welch V, Kett D, Scerpella E, Peyrani P, Ford K, et al.
J Womens Health (Larchmt)
. 2013 Oct;
22(12):1069-75.
PMID: 24128006
Background: The objective of this analysis was to evaluate the association between gender and clinical outcomes in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) since data thus far...
18.
Bassetti M, Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett D, et al.
Intensive Care Med
. 2013 Oct;
39(12):2092-106.
PMID: 24105327
Introduction: intra-abdominal candidiasis (IAC) may include Candida involvement of peritoneum or intra-abdominal abscess and is burdened by high morbidity and mortality rates in surgical patients. Unfortunately, international guidelines do not...
19.
Harris A, Pineles L, Belton B, Johnson J, Shardell M, Loeb M, et al.
JAMA
. 2013 Oct;
310(15):1571-80.
PMID: 24097234
Importance: Antibiotic-resistant bacteria are associated with increased patient morbidity and mortality. It is unknown whether wearing gloves and gowns for all patient contact in the intensive care unit (ICU) decreases...
20.
Munoz-Price L, Arheart K, Nordmann P, Boulanger A, Cleary T, Alvarez R, et al.
Crit Care Med
. 2013 Aug;
41(12):2733-42.
PMID: 23982021
Objective: To characterize the descriptive and molecular epidemiology of Acinetobacter baumannii in our hospital. Design: Longitudinal analysis of electronic microbiology laboratory records and isolates. Setting: A 1,500 bed public teaching...